Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
A genetically reshaped human IgG1 monoclonal antibody (CAMPATH-1H) was used to treat two patients with non-Hodgkin lymphoma. Doses of 1-20 mg daily were given intravenously for up to 43 days. In both patients lymphoma cells were cleared from the blood and bone marrow and splenomegaly resolved. One p...
Những tác giả chính: | Hale, G, Dyer, M, Clark, MR, Phillips, J, Marcus, R, Riechmann, L, Winter, G, Waldmann, H |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1988
|
Những quyển sách tương tự
-
REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
Bằng: Dyer, M, et al.
Được phát hành: (1990) -
Specificity of monoclonal antibody Campath-1.
Bằng: Hale, G, et al.
Được phát hành: (1988) -
CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
Bằng: Hale, G, et al.
Được phát hành: (1994) -
EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
Bằng: Dyer, M, et al.
Được phát hành: (1988) -
Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
Bằng: Waldmann, H, et al.
Được phát hành: (1985)